Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Downregulated YTHDF2 expression in systemic lupus erythematosus is associated with inflammatory and neutrophil cytokine production. | Clin Rheumatol | 2025 | 39668303 | PubTator, text mining | PubMed |
| MRTX1133 attenuates KRASG12D mutated-colorectal cancer progression through activating ferroptosis activity via METTL14/LINC02159/FOXC2 axis. | Transl Oncol | 2025 | 39657309 | PubTator, text mining | PubMed |
| m6A-related genes ALKBH5 and RBMX as prognostic and progression biomarkers in Chinese oral squamous cell carcinoma patients. | Arch Oral Biol | 2025 | 39643954 | PubTator, text mining | PubMed |
| Impact of METTL3/14/16 Gene Polymorphisms on Risk of Breast Cancer in Chinese Women. | Clin Breast Cancer | 2025 | 39643550 | PubTator, text mining | PubMed |
| Statistical modeling of single-cell epitranscriptomics enabled trajectory and regulatory inference of RNA methylation. | Cell Genom | 2025 | 39642887 | PubTator, text mining | PubMed |
| BAICALIN ALLEVIATES LPS-INDUCED CYTOTOXICITY IN ACUTE LUNG INJURY THROUGH MEDIATING METTL14/SOX6 AXIS. | Shock | 2025 | 39617417 | PubTator, text mining | PubMed |
| Gan-Jiang-Ling-Zhu decoction improves steatohepatitis induced by choline-deficient-high-fat-diet through the METTL14/N6-methyladenosine-mediated Ugt2a3 expression. | J Ethnopharmacol | 2025 | 39580132 | PubTator, text mining | PubMed |
LINC00882, transcriptionally activated by CEBP-β and post-transcriptionally stabilized by METTL14-mediated m6A modification, exerts tumorigenesis by promoting PABPC1-mediated stabilization of ELK3 mRNA. | Oncogene | 2025 | 39551868 | PubTator, text mining | PubMed |
| METTL14 attenuates cancer stemness by suppressing ATF5/WDR74/β-catenin axis in gastric cancer. | Cancer Sci | 2025 | 39497511 | PubTator, text mining | PubMed |
| Regulatory role and molecular mechanism of METTL14 in vascular endothelial cell injury in preeclampsia. | Biomol Biomed | 2025 | 39319864 | PubTator, text mining | PubMed |
| METTL14/IGF2BP2-MEDIATED M6A MODIFICATION OF STEAP1 AGGRAVATES ACUTE LUNG INJURY INDUCED BY SEPSIS. | Shock | 2025 | 39193903 | PubTator, text mining | PubMed |
| Enhancing m6A modification in the motor cortex facilitates corticospinal tract remodeling after spinal cord injury. | Neural Regen Res | 2025 | 39104113 | PubTator, text mining | PubMed |
| METTL14 Promotes Proliferation, Migration, and Invasion in Endometriotic Stromal Cell Growth by Activating the ZEB1/MEK/ERK Pathway. | Gynecol Obstet Invest | 2025 | 38934184 | PubTator, text mining | PubMed |
| RNA Metabolism and the Role of Small RNAs in Regulating Multiple Aspects of RNA Metabolism. | Noncoding RNA | 2024 | 39846679 | PubTator, text mining | PubMed |
| Association between METTL14 gene polymorphisms and risk of ovarian endometriosis. | Front Genet | 2024 | 39831202 | PubTator, text mining | PubMed |
| Methyltransferase-like 14 promotes the tumorigenesis and proliferation of pancreatic cancer cells through myc proto-oncogene signaling pathway. | Cytojournal | 2024 | 39737122 | PubTator, text mining | PubMed |
| Mettl3-Mediated m6A Modification is Essential for Visual Function and Retinal Photoreceptor Survival. | Invest Ophthalmol Vis Sci | 2024 | 39728691 | PubTator, text mining | PubMed |
| Patent landscape of small molecule inhibitors of METTL3 (2020-present). | Expert Opin Ther Pat | 2024 | 39721070 | PubTator, text mining | PubMed |
| Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14. | Sci Adv | 2024 | 39705353 | PubTator, text mining | PubMed |
| Epigenetic control of dental stem cells: progress and prospects in multidirectional differentiation. | Epigenetics Chromatin | 2024 | 39623487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=21